Autopsy report · NCT02707900

Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection

“Manufacturing of the AGS-004 HIV vaccine by Argos could no longer be provided.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 4 months before it stopped.
• 6 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

University of North Carolina, Chapel Hill

Sponsor type

University, hospital or other

Conditions

HIV-1 Infection

Interventions

Vorinostat; AGS-004

Participants

6

Sites

1

Countries

United States

Trials that died the same way

• Personalized Tumor Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma
  “Vaccine manufacturing has been suspended” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.